Log in
NASDAQ:PMVP

PMV Pharmaceuticals Stock Forecast, Price & News

$35.05
+0.01 (+0.03 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$34.32
Now: $35.05
$36.00
50-Day Range N/A
52-Week Range
$31.50
Now: $35.05
$42.93
Volume95,560 shs
Average Volume268,954 shs
Market Capitalization$1.51 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PMV Pharmaceuticals, Inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. Its lead product candidate is PC14586, a small molecule that corrects and restores p53 function. The company also develops product candidates for p53 R273H hotspot mutation and other p53 hotspot mutations. PMV Pharmaceuticals, Inc. was formerly known as PJ Pharmaceuticals, Inc. and changed to in July 2013. The company was founded in 2013 and is headquartered in Cranbury, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.68 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PMVP
CUSIPN/A
CIKN/A
Phone609 642 6670
Employees38

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$1.51 billion
Next Earnings DateN/A
OptionableNot Optionable
$35.05
+0.01 (+0.03 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PMVP News and Ratings via Email

Sign-up to receive the latest news and ratings for PMVP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PMV Pharmaceuticals (NASDAQ:PMVP) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of PMV Pharmaceuticals?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PMV Pharmaceuticals in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for PMV Pharmaceuticals
.

What price target have analysts set for PMVP?

4 brokers have issued 12-month target prices for PMV Pharmaceuticals' stock. Their forecasts range from $34.00 to $42.00. On average, they anticipate PMV Pharmaceuticals' share price to reach $38.00 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.
View analysts' price targets for PMV Pharmaceuticals
.

Who are some of PMV Pharmaceuticals' key competitors?

What other stocks do shareholders of PMV Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PMV Pharmaceuticals investors own include Vical (VICL), Arista Networks (ANET), Apollo Medical (AMEH), Advanced Micro Devices (AMD), Ambarella (AMBA), Alexion Pharmaceuticals (ALXN), Akoustis Technologies (AKTS), Agios Pharmaceuticals (AGIO), Admiral Group plc (ADM.L) (ADM) and Adobe (ADBE).

Who are PMV Pharmaceuticals' key executives?

PMV Pharmaceuticals' management team includes the following people:
  • Dr. David H. Mack, Co-Founder, CEO, Pres & Director (Age 58)
  • Dr. Arnold J. Levine Ph.D., Co-Founder, Independent Director & Member of Scientific Advisory Board (Age 80)
  • Dr. Thomas E. Shenk, Co-Founder & Member of Scientific Advisory Board (Age 73)
  • Mr. Winston Kung, COO & CFO (Age 44)
  • Mr. Robert Ticktin, Gen. Counsel (Age 58)

When did PMV Pharmaceuticals IPO?

(PMVP) raised $126 million in an initial public offering on Friday, September 25th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, BofA Securities, Cowen and Evercore ISI served as the underwriters for the IPO.

What is PMV Pharmaceuticals' stock symbol?

PMV Pharmaceuticals trades on the NASDAQ under the ticker symbol "PMVP."

When does the company's quiet period expire?

PMV Pharmaceuticals' quiet period expires on Wednesday, November 4th. PMV Pharmaceuticals had issued 11,765,000 shares in its public offering on September 25th. The total size of the offering was $211,770,000 based on an initial share price of $18.00. During the company's quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of PMV Pharmaceuticals?

Shares of PMVP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PMV Pharmaceuticals' stock price today?

One share of PMVP stock can currently be purchased for approximately $35.05.

How big of a company is PMV Pharmaceuticals?

PMV Pharmaceuticals has a market capitalization of $1.51 billion. PMV Pharmaceuticals employs 38 workers across the globe.

What is PMV Pharmaceuticals' official website?

The official website for PMV Pharmaceuticals is www.pmvpharma.com.

How can I contact PMV Pharmaceuticals?

The company can be reached via phone at 609 642 6670.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.